| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/17/2013 | EP2613795A2 Treatment of diseases |
| 07/17/2013 | EP2613775A1 Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/17/2013 | EP2517700B1 Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation |
| 07/17/2013 | CN1568329B Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 07/17/2013 | CN103209979A Therapeutic agents 976 |
| 07/17/2013 | CN103209964A Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 07/17/2013 | CN103209962A Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 07/17/2013 | CN103209954A 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists |
| 07/17/2013 | CN103209697A Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients |
| 07/17/2013 | CN103209692A Novel treatment of multiple sclerosis (MS) |
| 07/17/2013 | CN103205337A Glutinous rice wine prepared with sunflower discs and gynostemma pentaphyllum and preparation method thereof |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103204920A Novel epidermal growth factors and applications for same |
| 07/17/2013 | CN103204860A Amaryllidaceae alkaloids compound with neuroprotective effect |
| 07/17/2013 | CN103204852A Heteroaryl amide analogues as P2X7 antagonists |
| 07/17/2013 | CN103204827A Benzothiadiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204822A Benzoxazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204813A Condensed imidazole derivatives as TRPV3 antagonist |
| 07/17/2013 | CN103204782A Levocarnitine compound |
| 07/17/2013 | CN103203020A Application of statin medicines in preparing medicines used for treating chronic subdural hematoma |
| 07/17/2013 | CN103202999A Modified peach pit flatus-smoothing oral liquid used for operative complications and preparation method thereof |
| 07/17/2013 | CN103202989A Heart nourishing and brain invigorating traditional Chinese medicinal preparation for treating amnesia |
| 07/17/2013 | CN103202982A Chinese patent medicine oral administration pills for treating encephalanalosis |
| 07/17/2013 | CN103202964A Brain-improving and mind-calming medicinal liquor |
| 07/17/2013 | CN103202957A Traditional Chinese medicine composition for treating megrim |
| 07/17/2013 | CN103202948A Medicinal liquor with kidney tonifying and hair blacking functions |
| 07/17/2013 | CN103202944A Orally-administered traditional Chinese medicine for treating hemiplegia hemihidrosis |
| 07/17/2013 | CN103202896A Tranquillizing, allaying and sleep-promoting oral liquid and preparation method thereof |
| 07/17/2013 | CN103202874A Miao medicine formula for treating primary epileptic disease |
| 07/17/2013 | CN103202865A Micronized Chinese yew particles, compound for health bath obtained by using Chinese yew micronized particle and preparation method thereof |
| 07/17/2013 | CN103202845A Pharmaceutical Composition Of A Sodium Channel Blocker And A Selective Serotonin Uptake Inhibitor |
| 07/17/2013 | CN103202840A Salts Of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 07/17/2013 | CN103202831A A method for preparing derivatives of a specific monomer danshensu and the application of the danshensu derivatives in the pharmaceuticals |
| 07/17/2013 | CN103202815A Injection for treating mental disease |
| 07/17/2013 | CN103202641A Cervical adjustment treating medicine pillow |
| 07/17/2013 | CN103202575A Tujia brocade health-preserving shoe pads |
| 07/17/2013 | CN102631581B Medicament for treating agrypnia and production method thereof |
| 07/17/2013 | CN102558297B Endomorphin-1 analogue modified by alpha-alkenyl-beta-amino acid and composition and application thereof |
| 07/17/2013 | CN102552794B Stasis removing and pain relieving decotion for treating migraine |
| 07/17/2013 | CN102552581B Medicament for treating insomnia |
| 07/17/2013 | CN102552211B Preparation composite of agomelatine and preparation method thereof |
| 07/17/2013 | CN102525997B Moisture-proof coating citicoline sodium capsule and preparation method thereof |
| 07/17/2013 | CN102361638B Transdermal preparation |
| 07/17/2013 | CN102186477B Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| 07/17/2013 | CN102172351B Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 07/17/2013 | CN102159215B Treating various disorders using TrkB agonists |
| 07/17/2013 | CN102083820B Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 07/17/2013 | CN102066345B Oxazolidine derivatives as NMDA antagonists |
| 07/17/2013 | CN102030771B Compound used as transient receptor potential vanilloid (TRPV1) blocker, medicinal composition and pharmaceutical application thereof |
| 07/17/2013 | CN102002052B Ginkgolides K and compound thereof as well as preparation method and use thereof |
| 07/17/2013 | CN101928329B Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 07/17/2013 | CN101619056B Benzothiophene alkanol piperazine derivatives and use thereof as antidepressant medicaments |
| 07/17/2013 | CN101528225B 2-aminobenzoxazole carboxamides as 5HT3 modulators |
| 07/17/2013 | CN101485650B Diclofenac sodium and lidocaine hydrochloride injection and preparation method thereof |
| 07/17/2013 | CN101405054B Compositions and methods for preserving brain function |
| 07/17/2013 | CN101060860B Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| 07/16/2013 | US8487099 Gamma secretase modulators |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486948 Piperazinodihydrothienopyrimidine derivatives |
| 07/16/2013 | US8486937 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof |
| 07/16/2013 | US8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 07/16/2013 | US8486886 Botulinum toxin treatments |
| 07/16/2013 | US8486698 Inducing differentiation of an isolated marrow stromal cell into a neuronal cell tissue engineering for use in prevention and treatment of nervous system disorders; regenerative medicine; tissue engineering |
| 07/16/2013 | US8486696 Cell populations which co-express CD49c and CD90 |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | US8486442 External patch containing estrogen and/or progestogen |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF |
| 07/16/2013 | US8486385 Methods for therapy of neurodegenerative disease of the brain |
| 07/16/2013 | CA2711508C Proline analogs as ligands for cannabinoid receptors |
| 07/16/2013 | CA2699674C 5-ht7 receptor antagonists |
| 07/16/2013 | CA2697167C Benzimidazole derivatives used as fxr agonists |
| 07/16/2013 | CA2641830C Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders |
| 07/16/2013 | CA2583983C Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/16/2013 | CA2569826C Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 07/16/2013 | CA2547645C Use of rotigotine for the treatment or prevention of dopaminergic neuron loss |
| 07/16/2013 | CA2526695C Selection of allosteric regulators with class iii g protein-coupled receptors depleted of the extracellular domain |
| 07/16/2013 | CA2493888C Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| 07/16/2013 | CA2490542C Fas peptide mimetics and uses thereof |
| 07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
| 07/16/2013 | CA2483980C Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 07/16/2013 | CA2483120C Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome |
| 07/16/2013 | CA2464656C Spray drying methods and compositions thereof |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/11/2013 | WO2013103972A1 Treatment of frailty syndrome and symptoms thereof |
| 07/11/2013 | WO2013103964A1 Methods and compositions for treating proteinopathies |
| 07/11/2013 | WO2013103867A1 Benzenesulfonamide derivative for use in the treatment of diabetic neuropathy |
| 07/11/2013 | WO2013103746A1 Methods of treating behavioral symptoms of neurological and mental disorders |
| 07/11/2013 | WO2013103318A1 Solid nicotine-comprising dosage form with reduced organoleptic disturbance |
| 07/11/2013 | WO2013102897A1 Polymorphs of perampanel |
| 07/11/2013 | WO2013102265A1 Compositions and methods for treating multiple sclerosis |
| 07/11/2013 | WO2013102242A1 Heterocyclic compounds and methods for their use |
| 07/11/2013 | WO2013087808A8 Pharmaceutical composition comprising a pyrazolopyrimidine and cyclodextrin |
| 07/11/2013 | WO2013070981A3 Treating er stress related disorders by stabilizing intracellular calcium homeostasis |
| 07/11/2013 | WO2013067105A3 Nicotinic receptor non-competitive modulators |
| 07/11/2013 | WO2013059791A3 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders |
| 07/11/2013 | WO2013057687A3 Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment |
| 07/11/2013 | WO2013057554A3 Therapeutic combinations of netupitant and palonosetron |
| 07/11/2013 | WO2013052787A3 Membrane activated chelators and use in the prevention and treatment of parasitic infection |
| 07/11/2013 | WO2013042943A3 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medicinal-plant-derived ligand |